CN106668190A - Chinese herbal compound external preparation for treating haemorrhoids - Google Patents
Chinese herbal compound external preparation for treating haemorrhoids Download PDFInfo
- Publication number
- CN106668190A CN106668190A CN201611245919.2A CN201611245919A CN106668190A CN 106668190 A CN106668190 A CN 106668190A CN 201611245919 A CN201611245919 A CN 201611245919A CN 106668190 A CN106668190 A CN 106668190A
- Authority
- CN
- China
- Prior art keywords
- parts
- external preparation
- chinese medicine
- hemorrhoid
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 47
- 239000002674 ointment Substances 0.000 claims abstract description 29
- 230000000694 effects Effects 0.000 claims abstract description 16
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 14
- 239000000443 aerosol Substances 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000006210 lotion Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 18
- 241000125175 Angelica Species 0.000 claims description 13
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 241000219053 Rumex Species 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000007796 conventional method Methods 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 13
- 210000000436 anus Anatomy 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 10
- 208000032843 Hemorrhage Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 208000034158 bleeding Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- -1 polyoxyethylene Polymers 0.000 description 7
- 229940099259 vaseline Drugs 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 208000016583 Anus disease Diseases 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 229940039717 lanolin Drugs 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010002153 Anal fissure Diseases 0.000 description 4
- 208000009531 Fissure in Ano Diseases 0.000 description 4
- 240000004980 Rheum officinale Species 0.000 description 4
- 235000008081 Rheum officinale Nutrition 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- YQEMORVAKMFKLG-UHFFFAOYSA-N 2-stearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 201000007772 internal hemorrhoid Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003883 ointment base Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000019751 Anorectal disease Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 201000007783 perianal hematoma Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 235000011185 polyoxyethylene (40) stearate Nutrition 0.000 description 1
- 239000001194 polyoxyethylene (40) stearate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of traditional Chinese medicines, in particular to a Chinese herbal compound external preparation for treating haemorrhoids. The Chinese herbal compound external preparation for treating the haemorrhoids is prepared from the following raw materials in parts by weight: 30-90 parts of radix rumicis japonici, 5-30 parts of honeysuckle flower, 1-30 parts of radix angelicae dahuricae and 5-40 parts of liquorice root. The composition provided by the invention can be prepared into needed external preparations such as ointment, aerosol and lotion by means of simple physical crushing or extraction and refining; the Chinese herbal compound external preparation is reasonable in medicine formula; the prepared preparation has the characteristics of being free from toxic and side effect, convenient to use, and the like, has the function of treating or improving hemorrhoidal bleeding, and is definite in clinical effect, remarkable in curative effect and quick in response.
Description
Technical field
The present invention relates to the field of Chinese medicines, and in particular to a kind of Chinese medicine compound prescription external preparation for treating hemorrhoid.
Background technology
Anal and bowel pile is commonly called as hemorrhoid, is a kind of common disease, frequently-occurring disease.Mainly under rectum end mucous membrane, anal tube and anus
There is the venous group that expansion, varicose form softness in the subcutaneous veniplex of door edge;Or anus edge pleat chafing, hypertrophy, knot
Form hyperblastosis;Or anal veins rupture, the stagnant formation thrombus of the blood stasis of blood.
In recent years due to the change of dietary structure and eating habit, hyperpyrexia, pungent, heavy wool become quite a few state of China
The diet taste of the people, the incidence of disease for making hemorrhoid substantially rises.Hemorrhoid are a kind of common diseases being detrimental to health, multiple
Disease, shows according to relevant information, and the incidence of disease of anorectal disease is 59.1%, and hemorrhoid account for the 87.25% of all recial diseases, account for institute
Have the 52.19% of anal and intestinal disease.Men and women can fall ill, and women is more than the male sex, and any age all can fall ill, wherein 20~40 years old
People is more common, and gradually increases with the growth at age more, and this disease is most commonly seen with bleeding, pain, the big symptom of constipation three.According to
The difference of disease locus, can be divided into internal piles, external piles and mixed hemorrhoid three types.At present, treatment of the modern medicine to this disease, generally
Using oral medicinal herb, outward control and the treatment method such as acupuncture, operation, treatment method of taking medicine is divided into medicine for oral administration and externally applied drug treatment,
Surgical intervention curative effect is not very good, and treatment time is long, affects work, this treatment method both to cause economical negative to patient
Load, causes body and mind pain again.
Have many using Chinese medicines that are oral or applying outward or Western medicine in prior art, but the curative effect that these medicines have not substantially,
Easily recurrence, treatment cycle are long.
The content of the invention
The purpose of the present invention is the not enough effect treatment hemorrhoid short there is provided a kind of effective in cure good, treatment cycle for more than
Chinese medicine compound prescription external preparation.
To realize object above, the present invention is achieved by the following technical programs:
A kind of Chinese medicine compound prescription external preparation for treating hemorrhoid, is made up of the raw material of following heavy number:30~90 parts of Rumex madaio,
5~30 parts of honeysuckle, 1~30 part of the root of Dahurain angelica, 5~40 parts of Radix Glycyrrhizae.
Preferably, the Chinese medicine compound prescription external preparation of the treatment hemorrhoid is made up of the raw material of following heavy number:Rumex madaio 45
~80 parts, 6~25 parts of honeysuckle, 5~15 parts of the root of Dahurain angelica, 6~25 parts of Radix Glycyrrhizae.
Preferably, the Chinese medicine compound prescription external preparation of the treatment hemorrhoid is made up of the raw material of following heavy number:Rumex madaio 60
Part, 18 parts of honeysuckle, 6 parts of the root of Dahurain angelica, 18 parts of Radix Glycyrrhizae.
The Chinese medicine compound prescription external preparation of the treatment hemorrhoid in the present invention can be prepared by following methods:
(1) weigh each bulk drug by formula ratio, in input extractor, add the mixture of water or water and ethanol as molten
Agent, decocts 1h, collects filtrate, and so repeatedly 2~3 times, merging filtrate is filtered, and obtains extract;By the extract in 70~80
The thick paste that relative density is 1.12~1.20 is condensed at DEG C, activity extract is obtained final product, it is standby;
(2) step (1) gained activity extract is made clinically according to common process and pharmaceutically acceptable carrier
Acceptable external preparation.
Wherein, the clinically acceptable external preparation includes but is not limited to ointment, lotion, aerosol.
The preparation method of ointment is:The various matrix of ointment are added in above-mentioned steps (1) gained activity extract,
Externally-applied soft ointment is made with common process.
Lotion, production of aerosol are:Customary adjuvant is added in above-mentioned steps (1) gained activity extract, with normal
Rule technique makes lotion, aerosol.
The Chinese medicine compound prescription external preparation of the treatment hemorrhoid in the present invention can also be prepared by following methods:
(1) each bulk drug is weighed by formula ratio, each bulk drug is ground to form into impalpable powder by conventional method, obtain Chinese medicine superfine
Powder, it is standby;
(2) the various matrix of ointment are added in step (1) gained Chinese medicine impalpable powder, ointment is made with common process
Agent.
The preferred ointment of external preparation of the present invention.Ointment according to decentralized system can be divided into solution-type, suspension type and
Ointment.Some additives such as preservative, penetrating agent, surfactant, penetrating agent, nitrogen can also be added in ointment bases
Ketone, propane diols, glycerine, polyethylene glycol, the preferred DMSO of penetrating agent.The preferred non-ionic surfactant of surfactant, such as aliphatic acid
Sorb is smooth, polysorbate, polyoxyethylene fatty acid ester, polyoxyethylene aliphatic alcohol ether, the preferred ethyl-para-hydroxybenzoate of preservative.
Lotion of the present invention is, by the concentration of active ingredient of Chinese herbs extract, to add appropriate preservative, and is added certain
The thickener of amount, is well mixed prepared.The preferred suspension aerosol of aerosol of the present invention, active ingredient of Chinese herbs is extracted
Thing is dried, and then carries out nanosizing process, adds a certain amount of supensoid agent and propellant, bottling to obtain final product.
Matrix of the present invention includes:
1st, conventional oleaginous base such as globefish oil, vegetable oil, sesame oil, cottonseed oil, peanut oil, hydrogenated vegetable oil;
2nd, hydro carbons such as vaseline, ceresine, atoleine;
3rd, lipoid such as lanolin, lanonol, beeswax, cera alba, spermaceti, cholesterol;
4th, emulsion-type matrix such as stearic acid, cetanol, stearyl alcohol, lauryl sodium sulfate;Sodium stearyl sulfate, glycerine
Monostearate, polyglycerol stearate, tween, polyoxyethylene (40) stearate, double calcium stearates, double stearic acid aluminium, department
Disk;
5th, water-soluble base such as glycerin gelatine, glycerinum amyli, sodium alginate, polyethylene glycol, methylcellulose, carboxymethyl is fine
The plain sodium of dimension.
The mixture of the preferred vaseline of ointment bases, lanolin and vaseline and lanolin in the present invention.When soft
When cream base matter is the mixture of vaseline and lanolin, the part by weight preferably 1 of vaseline and lanolin:1.
The bulk drug property of medicine used in the present invention is as follows:
Rumex madaio:Cool, pungent, hardship, with the heat-clearing row stasis of blood, desinsection, removing toxic substances work(, for treat hemoptysis, lung carbuncle, rib inflammation,
Constipation, carbuncle swells poison, eczema, mange etc..Return through lung spleen, large intestine channel.Modern pharmacological research shows that Rumex madaio has antibacterial, stops
Blood, it is antitumor, anti-oxidant, etc. pharmacological action.
Honeysuckle:Sweet, slight bitter, it is pungent, tremble with fear.Return lung, stomach, the heart, large intestine channel.Honeysuckle containing inositol, flavonoids, inositol,
The various pathogens such as staphylococcus aureus, shigella dysenteriae, with broad-spectrum antibacterial action, are had stronger suppression to make by tannin etc.
With also having inhibitory action to multiple pathogenic microorganisms such as Leptospira, influenza virus and pathogenic moulds.
The root of Dahurain angelica:It is pungent, temperature.Attach to the lung and stomach meridians.Expelling wind and clearing away cold, sensible pain relieving, apocenosis of invigorating blood circulation, myogenic pain relieving, eliminating dampness stops band.With
In headache, toothache, nasosinusitis, intestines wind anal fistula, leukorrhea with reddish discharge, ulcer sores, pruitus.Modern pharmacological research proves that the root of Dahurain angelica also has
There are anti-inflammatory, antipyretic-antalgic etc. to act on.
Radix Glycyrrhizae:It is sweet, flat, the thoughts of returning home, lung, spleen, stomach.Invigorate the spleen and benefit qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain reconciles all
Medicine.For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, four limbs contraction, carbuncle sore tumefacting virus, abirritant
It is thing toxicity, strong;Its active ingredient is glycyrrhizin, enoxolone, 4',7-Dihydroxyflavanone, licorice polysaccharide are clinically conventional medium-height grass
One of medicine.
Beneficial effects of the present invention are:
The present invention adopts pure plant for raw material, or the active component in Chinese medicine material is extracted, using the modern times
Preparation technique, is made into the pharmaceutically acceptable preparation such as ointment, lotion or aerosol, this pharmaceutical composition Jing science
It is compatibility, reasonably combined, be conducive to treating thrombosed external hemorrhoid, inflammatory external hemorrhoid, with curative effect it is high, can thoroughly effect a radical cure, no longer recurrence, nothing
Any side effect, treatment no pain, the low feature of medical expense, and work is not affected in therapeutic process.
Specific embodiment
The technical solution of the present invention is further illustrated with reference to specific embodiment, embodiment is not to be construed as right
The restriction of technical solution.
Embodiment 1:Ointment
Chinese medicine preparation:60 parts of Rumex madaio, 18 parts of honeysuckle, 6 parts of the root of Dahurain angelica, 18 parts of Radix Glycyrrhizae.
Preparation method:By in the medicinal material input extractor of above-mentioned formula ratio, the decocting for adding 10 times of amounts boils 1h, collects filter
Liquid, so repeatedly 3 times, after filtration, merges all of filtrate, filters, and discards residue, extract is obtained, by the extract in 70
The thick paste that relative density is 1.20 is condensed at DEG C, dry cream is sprayed into, fine powder is then comminuted into, the dusting cover crossed more than 150 mesh, institute
Obtain fine powder to be added in 80 DEG C of vaseline, stir, to into paste, cooling, obtain final product the ointment for the treatment of hemorrhoid.
Embodiment 2:Lotion
Chinese medicine preparation:30 parts of rheum officinale, 30 parts of honeysuckle, 15 parts of the root of Dahurain angelica, 40 parts of Radix Glycyrrhizae.
Preparation method:By in the medicinal material input extractor of above-mentioned formula ratio, the decocting for adding 10 times of amounts boils 1h, collects filter
Liquid, so repeatedly 3 times, merges all of filtrate, filters, and discards residue, obtains extract, and the extract is concentrated at 80 DEG C
It is standby into the thick paste that relative density is 1.12;It is subsequently adding sodium carboxymethyl starch and Sodium Benzoate is well mixed, is configured to afterwards
Solution, obtains final product the lotion for the treatment of hemorrhoid.
Embodiment 3:Aerosol
Chinese medicine preparation:80 parts of rheum officinale, 6 parts of honeysuckle, 30 parts of the root of Dahurain angelica, 5 parts of Radix Glycyrrhizae.
Preparation method:By in the medicinal material input extractor of above-mentioned formula ratio, the decocting for adding 10 times of amounts boils 1h, collects filter
Liquid, so repeatedly 2 times, merges all filtrates, discards residue, obtains extract, and the extract is condensed into relatively at 70 DEG C
Density is 1.20 thick paste, and nanosizing process is carried out after dried process, be eventually adding appropriate F-11, appropriate two
Dichlorodifluoromethane and appropriate three oleic acid sorbitol ester, load tracheae bottle, obtain final product the aerosol for the treatment of hemorrhoid.
Embodiment 4:Ointment
Chinese medicine preparation:90 parts of rheum officinale, 5 parts of honeysuckle, 1 part of the root of Dahurain angelica, 25 parts of Radix Glycyrrhizae.
Preparation method:The medicinal material of above-mentioned formula ratio is ground to form into impalpable powder, gained impalpable powder is added to 80 DEG C of vaseline
In, stir, to into paste, cooling, obtain final product the ointment for the treatment of hemorrhoid.
Embodiment 5:Ointment
Chinese medicine preparation:45 parts of rheum officinale, 25 parts of honeysuckle, 5 parts of the root of Dahurain angelica, 6 parts of Radix Glycyrrhizae.
Preparation method:By in the medicinal material input extractor of above-mentioned formula ratio, the decocting for adding 10 times of amounts boils 1h, collects filter
Liquid, so repeatedly 2 times, after filtration, merges all of filtrate, filters, and discards residue, extract is obtained, by the extract in 70
The thick paste that relative density is 1.15 is concentrated at DEG C, qs glycerin is added, is well mixed, and be incubated at 80 DEG C, obtain mixture one,
It is standby;
Separately take stearic acid, hexadecanol, glycerin monostearate, atoleine and be heated to 80~85 DEG C, make fusing, and mix
Uniformly, mixture two is obtained, then mixture two is slowly added in mixture one, and emulsify 5~6min, take out cooling, i.e.,
The ointment of hemorrhoid must be treated.
Clinical data:
1st, general data
To verify therapeutic effect of the Chinese medicine preparation of embodiment of the present invention preparation to hemorrhoid, hemorrhoid patients 130 are randomly choosed
Example carries out clinical observation.It is wherein male 78, female 52,20~65 years old age.130 patients are randomly divided into into test group and control
Group.
2nd, diagnostic criteria
Internal piles:Have difficulty in passing one's motions, there is a falling inflation sense, having a rest property of defecation time band blood, bleed or spray blood, haemorrhoids is deviate from.
External piles:Red and swollen heat pain, oedema, hyperemia substantially, there is tenderness, and pain increases during defecation, and has a small amount of secretion, has
Can be with general malaise and heating.
Mixed hemorrhoid:Have the symptom of inside and outside hemorrhoid concurrently.
All persons that has above-mentioned symptom, are diagnosed as hemorrhoid patients, can be chosen as clinical observation.
3rd, treatment method
Test group:First anus cleaned up during treatment, the ointment for then being prepared with embodiment 1 is applied to affected part, by affected part
All cover, Internal hemorrhoid hemorrhage can use 10 parts of ointment, injected in anus by noting anus device, it is daily sooner or later each 1 time, it is a treatment within 10th
Journey.
Control group:First anus cleaned up during treatment, is then taken jiuhua plaster and is applied to affected part in right amount, affected part is all covered
Lid, Internal hemorrhoid hemorrhage can use 10 parts of ointment and be injected in anus by note anus device, and the daily morning and evening is each once, be within 10th 1 course for the treatment of.
Two groups with treat 10 days as a course for the treatment of, statistics after 2 courses for the treatment of.
4th, efficacy assessment standard
Curative effect judging standard:With reference to《New Chinese medicine treats the guideline of clinical investigations of hemorrhoid》Voluntarily draft.
Recovery from illness:Haemorrhoids atrophy, clinical symptoms are eliminated, always without recurrence after treatment.
It is effective:Symptom is substantially achieved alleviation.
Take a turn for the better:Symptom makes moderate progress, and pain has mitigated, and needs the further treatment of medicine.
It is invalid:Symptom has pain without improvement, or even has the trend for increasing.
5th, treatment results
After by clinical observation, 1 is the results are shown in Table.
The clinical treatment outcome of table 1
Group | Case load | Recovery from illness | It is effective | Effectively | It is invalid | Total effective rate (%) |
Test group | 65 | 33 | 16 | 12 | 4 | 93.8 |
Control group | 65 | 12 | 14 | 14 | 15 | 76.9 |
6th, discuss
Chinese medicine preparation of the present invention has clearing heat and detoxicating, and promoting blood circulation and removing blood stasis, swelling and pain relieving liter carries admittedly de- work(, such that it is able to reach
Hemorrhoid are prevented or cure a disease the purpose removed.Clinical effectiveness shows, in test group in 65 61 effectively, total effective rate is up to 93.8% and cure rate
Height, therefore it is considered a kind of safely and effectively medicine.Ointment convenient drug administration, effect is significant, cure rate is high, and clinic is promoted and made
With.
7th, model case
Case 1
Lee, man, 50 years old, more than 2 years, sometimes pain must be difficult to stand anus, have blood in stool sometimes, at 1.5cm in anus for illness
There is old anal, and form an alliance and form tissue external piles, be diagnosed as old anal.
Treatment:Treated using the ointment in the embodiment of the present invention 1, it is daily sooner or later each 1 time, it is applied in affected part.Make
With 1 week, pain and swelling disappeared substantially, stable disease.It is continuing with 10, fully recovers, items checks normal, and follow-up 2 years is not multiple
Send out.
Case 2
Certain is thanked, man, 42 years old, hemorrhoid 4 years, haemorrhoids is bigger, and quality is harder, surface micro-strip canescence, haemorrhoids abjection when just
Outside anus, or even walking, cough, sneeze or can also deviate from when standing, it is impossible to voluntarily Hui Na, must be returned with hand push, or prostration, hot compress
After can Hui Na, few or no longer bleeding of having blood in stool.
Treatment:Treated using the ointment in the embodiment of the present invention 1, it is daily sooner or later each 1 time, affected part is applied in, make
With 3 days, symptom slightly alleviation, following the service was used 7, and symptom difference is light, and stable, is continuing with, and using more than 1 month, haemorrhoids was certainly
Row add-back is received, no longer bleeding, recovery from illness, and items check normal, and follow-up 3 years is not recurred.
Case 3
Zhang, female 33 years old, suffered from hemorrhoid and anal fissure before 3 years, i.e. bleeding of defecating.
Treatment:Treated using the ointment in the embodiment of the present invention 4, it is daily sooner or later each 1 time, affected part is applied in, make
With 24h, anal fissure, having blood in stool significantly improves, and using this paste 2 weeks, anal fissure and having blood in stool was clearly better following the service.Paste of the present invention is used again
More than January, anal fissure and stool disappear to the greatest extent, fully recover, follow-up so far there are no recurrence.
Case 4
27 years old, there is lump abjection in anus from period of gestation in Liu, women, and with bleeding during stool, does not come in time
Hospital therapy, the state of an illness constantly increases.Lump developed into by one it is multiple, two weeks defecate every time occur spray mass formed by blood stasis shape, go out
It is existing dizzy, the symptom such as weak.
Treatment:Treated using the ointment in the embodiment of the present invention 5, it is daily sooner or later each 1 time, affected part is applied in, make
With 24h, the withered atrophy of haemorrhoids comes off, stopped bleeding.After 1 week, normal diet and defecation.Smooth without obvious scar at anus after several months
, without bleeding, stool is normal, pays a return visit without exception after 1 year for trace.
Claims (7)
1. a kind of Chinese medicine compound prescription external preparation for treating hemorrhoid, it is characterised in that be made up of the raw material of following heavy number:Rumex madaio
30~90 parts, 5~30 parts of honeysuckle, 1~30 part of the root of Dahurain angelica, 5~40 parts of Radix Glycyrrhizae.
2. it is according to claim 1 treatment hemorrhoid Chinese medicine compound prescription external preparation, it is characterised in that by following heavy number
Raw material is made:45~80 parts of Rumex madaio, 6~25 parts of honeysuckle, 5~15 parts of the root of Dahurain angelica, 6~25 parts of Radix Glycyrrhizae.
3. it is according to claim 2 treatment hemorrhoid Chinese medicine compound prescription external preparation, it is characterised in that by following heavy number
Raw material is made:60 parts of Rumex madaio, 18 parts of honeysuckle, 6 parts of the root of Dahurain angelica, 18 parts of Radix Glycyrrhizae.
4. the Chinese medicine compound prescription external preparation of the treatment hemorrhoid according to any one of claim 1-3, it is characterised in that by following
Method is prepared:
(1) each bulk drug is weighed by recipe quantity, in input extractor, adds the mixture of water or water and ethanol as solvent, decocted
Boil 1h, collect filtrate, so repeatedly 2~3 times, merging filtrate is filtered, and obtains extract;By the extract at 70~80 DEG C
The thick paste that relative density is 1.12~1.20 is condensed into, activity extract is obtained final product, it is standby;
(2) making step (1) gained activity extract according to common process and pharmaceutically acceptable carrier clinically can connect
The external preparation received.
5. the Chinese medicine compound prescription external preparation for the treatment of hemorrhoid according to claim 4, it is characterised in that the external preparation is
Ointment, lotion or aerosol.
6. the Chinese medicine compound prescription external preparation for the treatment of hemorrhoid according to claim 4, it is characterised in that the external preparation is
Ointment.
7. the Chinese medicine compound prescription external preparation of the treatment hemorrhoid according to any one of claim 1-3, it is characterised in that by following
Method is prepared:
(1) each bulk drug is weighed by recipe quantity, each bulk drug is ground to form into impalpable powder by conventional method, obtain Chinese medicine impalpable powder,
It is standby;
(2) the various matrix of ointment are added in step (1) gained Chinese medicine impalpable powder, ointment is made with common process.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611245919.2A CN106668190A (en) | 2016-12-29 | 2016-12-29 | Chinese herbal compound external preparation for treating haemorrhoids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611245919.2A CN106668190A (en) | 2016-12-29 | 2016-12-29 | Chinese herbal compound external preparation for treating haemorrhoids |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106668190A true CN106668190A (en) | 2017-05-17 |
Family
ID=58873356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611245919.2A Pending CN106668190A (en) | 2016-12-29 | 2016-12-29 | Chinese herbal compound external preparation for treating haemorrhoids |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106668190A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105267316A (en) * | 2014-07-25 | 2016-01-27 | 高晓燕 | Hemorrhoid treating formula |
-
2016
- 2016-12-29 CN CN201611245919.2A patent/CN106668190A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105267316A (en) * | 2014-07-25 | 2016-01-27 | 高晓燕 | Hemorrhoid treating formula |
Non-Patent Citations (1)
Title |
---|
白苏子等: "《中华实用奇方全书》", 30 September 2013, 黑龙江科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106668190A (en) | Chinese herbal compound external preparation for treating haemorrhoids | |
CN108721442B (en) | Traditional Chinese medicine composition and preparation for treating burns, scalds and diaper dermatitis and preparation method thereof | |
WO2022011881A1 (en) | Medication for preventing and treating hemorrhoids and use thereof | |
CN102327406B (en) | Traditional Chinese medicine composition for promoting urination, and preparation method and application thereof | |
CN105343847A (en) | Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof | |
CN105770691A (en) | Medicinal preparation for treating cervical cancer and application thereof | |
CN105412861A (en) | Traditional Chinese medicine composition for treating tubal nowhere and preparation method thereof | |
CN107308305B (en) | Preparation for treating infantile eczema, dermatitis and infantile eczema | |
CN105012587A (en) | Medicinal preparation for treating epilepsy | |
CN1286515C (en) | Medicinal composition for treating cyst | |
CN110742923A (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation for treating parturient milk contraction and preparation method thereof | |
CN103520447A (en) | Externally used ointment suitable for anal fistula after operation | |
CN104523942B (en) | One treats colpitic external preparation | |
CN103495069B (en) | Pharmaceutical composition for treating postpartum neurosis intestinal obstruction | |
CN106729443A (en) | A kind of Chinese medicine composition for swelling and pain relieving and preparation method thereof | |
CN113786450A (en) | Lotion for haemorrhoids and preparation method and application thereof | |
CN101632729A (en) | Application of Chinese medicinal composition in preparing medicament for treating involution syndrome | |
CN104906439A (en) | Medicine for treating chronic respiratory failure | |
CN104800512A (en) | Chinese medicinal composition for treating lymphnoditis and preparation method | |
CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition | |
CN105106682A (en) | Internal traditional Chinese medicine for treating hemorrhoids | |
CN104840789A (en) | Hypotensive composition | |
CN103520541B (en) | Dressing umbilicus granule for treating postnatal neurosis intestinal obstruction and preparation method thereof | |
CN111388640A (en) | Pharmaceutical composition with functions of clearing away heat and toxic material, relieving cough and reducing sputum and preparation method thereof | |
CN113018396A (en) | Traditional Chinese medicine composition for treating recurrent urinary tract infection and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170517 |